Compounds > 2,2,2-trifluoro-1-(9-anthryl)ethanol
Page last updated: 2024-12-07

2,2,2-trifluoro-1-(9-anthryl)ethanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2,2-trifluoro-1-(9-anthryl)ethanol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID103802
SCHEMBL ID2482183
MeSH IDM0239963

Synonyms (57)

Synonym
2,2,2-trifluoro-1-(9-anthryl)ethanol
60686-64-8
alpha-(trifluoromethyl)-9-anthracenemethanol
T1522
1-(9-anthryl)-2,2,2-trifluoroethanol
65487-67-4
1-anthracen-9-yl-2,2,2-trifluoroethanol
1-(9-anthryl)-2,2,2-trifluoro-ethanol
A832841
1,2,3-trifluorobenzaldehyde;benzaldehyde, 2,3,4-trifluoro- (9ci)
A21292
2-(9-anthryl)-1,1,1-trifluoroethanol
pirkle's alcohol
FT-0676258
einecs 258-611-5
einecs 262-348-1
(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol
(s)-alpha-(trifluoromethyl)anthracene-9-methanol
unii-5k227fg858
5k227fg858 ,
einecs 265-791-9
alpha-(trifluoromethyl)anthracene-9-methanol
FT-0605025
FT-0605232
AKOS015852710
mfcd00062968
SCHEMBL2482183
9-anthracenemethanol, .alpha.-(trifluoromethyl)-
1-(9-anthryl)-2,2,2-trifluoroethanol #
AC-27934
mfcd00062967
1-(anthracen-9-yl)-2,2,2-trifluoroethanol
AS-66227
1-(anthracen-9-yl)-2,2,2-trifluoroethan-1-ol
Q15425266
(1r)-1-anthracen-9-yl-2,2,2-trifluoroethanol
DTXSID70968284
(1r)-1-(9-anthryl)-2,2,2-trifluoroethanol; (r)-(-)-1-(9-anthryl)-2,2,2-trifluoroethanol
9-anthracenemethanol, alpha-(trifluoromethyl)-, (r)-
.alpha.-(trifluoromethyl)-9-anthracenemethanol
1-(9-anthracenyl)-2,2,2-trifluoro-1-ethanol
(+/-)-2,2,2-trifluoro-1-(9-anthryl)ethanol
(+/-)-2,2,2-trifluoro-1-(anthracen-9-yl)ethanol
1-(anthracen-10-yl)-2,2,2-trifluoroethanol
dl-2,2,2-trifluoro-1-(9-anthryl)ethanol
(+/-)-2,2,2-trifluoro-1-(9-anthryl)-1-ethanol
2,2,2-trifluoro-1-(9-anthracenyl)ethanol
1-(9-anthryl)-2,2,2-trifluoro-1-ethanol
(rs)-2,2,2-trifluoro-1-(9-anthracenyl)ethanol
(+/-)-1-(9-anthryl)-2,2,2-trifluoroethanol
1-(9-anthryl)-2
T72786
SY076705
EN300-7403213
CS-0436386
(s)-1-(9-anthryl)-2,2,2-trifluoroethanol
SY061551
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.82 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
carbamates
[no description available]		2.4220amino-acid anion
glycine
[no description available]		2.0310alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
methanol
Methanol: A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.. primary alcohol : A primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.. methanol : The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group.		2.0810alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
econazole
Econazole: An imidazole derivative that is commonly used as a topical antifungal agent.. econazole : A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.. 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group.		2.0310dichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
ibuprofen
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine		8.3711monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
trifluoroethanol
Trifluoroethanol: A non-aqueous co-solvent that serves as tool to study protein folding. It is also used in various pharmaceutical, chemical and engineering applications.		4.871fluoroalcohol
2-naphthol
2-naphthol: RN given refers to parent cpd. 2-naphthol : A naphthol carrying a hydroxy group at position 2.. naphthols : Any hydroxynaphthalene derivative that has a single hydroxy substituent.		2.0310naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
(s)-binol
(1,1'-binaphthalene)-2,2'-diol: structure in first source		2.0310naphthols
2,2'-diamino-1,1'-dinaphthyl
2,2'-diamino-1,1'-dinaphthyl: structure in first source		2.0310
n-(3,5-dinitrobenzoyl)phenylglycine
N-(3,5-dinitrobenzoyl)phenylglycine: RN given for (R)-isomer		2.0310
quinidine
Quinidine: An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission.. quinidine : A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy.		2.4220cinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
ConditionIndicatedRelationship StrengthStudiesTrials
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		02.0210
Rheumatoid Arthritis
[description not available]		03.3711
Arthritis, Rheumatoid
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.		03.3711